tradingkey.logo

Catheter Precision Inc

VTAK
2.270USD
-0.130-5.42%
Fechamento 11/04, 16:00ETCotações atrasadas em 15 min
2.25MValor de mercado
PerdaP/L TTM

Catheter Precision Inc

2.270
-0.130-5.42%

Mais detalhes de Catheter Precision Inc Empresa

Catheter Precision, Inc. is a medical device company. It is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. It is focused on developing technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. It is also focused on developing and delivering electrophysiology products to provide patients, hospitals, and physicians with novel technologies and solutions to improve the lives of patients with cardiac arrhythmias. Its product is the VIVO System, which is an anacronym for View into Ventricular Onset System, which is a non-invasive imaging system that offers three-dimensional cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients. Its LockeT product is a suture retention device indicated for wound healing. Its product portfolio also includes the Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.

Informações de Catheter Precision Inc

Código da empresaVTAK
Nome da EmpresaCatheter Precision Inc
Data de listagemSep 27, 2018
CEOMr. David Jenkins
Número de funcionários22
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 27
Endereço1670 Highway 160 West
CidadeFORT MILL
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal29708
Telefone19736912000
Sitehttps://www.ramed.com/
Código da empresaVTAK
Data de listagemSep 27, 2018
CEOMr. David Jenkins

Executivos da empresa Catheter Precision Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
10.22K
-0.02%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
10.22K
-0.02%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
173.00K
81.60%
All other countries
39.00K
18.40%
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: sex, 29 de ago
Atualizado em: sex, 29 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Jenkins Family Charitable Institute
2.48%
Jenkins (David A)
0.69%
HRT Financial LP
0.62%
Citadel Advisors LLC
0.43%
UBS Financial Services, Inc.
0.26%
Outro
95.53%
Investidores
Investidores
Proporção
Jenkins Family Charitable Institute
2.48%
Jenkins (David A)
0.69%
HRT Financial LP
0.62%
Citadel Advisors LLC
0.43%
UBS Financial Services, Inc.
0.26%
Outro
95.53%
Tipos de investidores
Investidores
Proporção
Corporation
2.73%
Investment Advisor
0.98%
Individual Investor
0.83%
Hedge Fund
0.53%
Investment Advisor/Hedge Fund
0.19%
Research Firm
0.05%
Outro
94.68%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
23
26.16K
1.76%
-7.08K
2025Q2
30
1.62M
12.88%
+225.25K
2025Q1
34
1.39M
13.16%
+226.78K
2024Q4
37
1.12M
13.97%
-215.80K
2024Q3
45
563.38K
38.63%
+376.14K
2024Q2
46
202.02K
23.51%
+5.34K
2024Q1
50
211.28K
24.77%
+47.42K
2023Q4
52
169.47K
25.10%
+5.69K
2023Q3
56
180.73K
31.24%
+30.19K
2023Q2
57
168.19K
29.83%
+996.00
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Jenkins Family Charitable Institute
36.85K
2.48%
+10.53K
+39.98%
Jun 05, 2025
Jenkins (David A)
10.22K
0.69%
-2.00
-0.02%
Sep 10, 2025
HRT Financial LP
9.15K
0.62%
+9.15K
--
Jun 30, 2025
Citadel Advisors LLC
6.36K
0.43%
+4.63K
+266.74%
Jun 30, 2025
UBS Financial Services, Inc.
3.93K
0.26%
+3.88K
+7322.64%
Jun 30, 2025
FatBoy Capital LP
3.73K
0.25%
--
--
Jan 29, 2025
Geode Capital Management, L.L.C.
2.85K
0.19%
--
--
Jun 30, 2025
Caruso (James Joseph)
1.84K
0.12%
+10.00
+0.55%
Sep 10, 2025
Ground Swell Capital, LLC
1.45K
0.1%
+1.45K
--
Jun 30, 2025
Renaissance Technologies LLC
1.26K
0.08%
+1.26K
--
Jun 30, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Data
Tipo
Proporção
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Nov 16, 2020
Merger
25→1
Nov 16, 2020
Merger
25→1
Ver Mais
KeyAI